U.S. Markets open in 8 hrs 5 mins

Aeterna Zentaris Inc. (AEZS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.15+0.05 (+2.38%)
At close: 4:00PM EDT
People also watch
KERXCYCCAVEOGALEIMUC
  • D
    Doctor
    Doctor
    Hoping for a 50% pop by the end of the year. I think that's pretty conservative considering the last big jump.
  • z
    zack
    zack
    Let see if volume can pass 1.8 mil tomorrow . Increment increase is a good sign.
  • D
    Doctor
    Doctor
    These daily ups-and-downs don't excite or bother me. I'm waiting for the definite jump later this year.
  • r
    redheadadmirer
    redheadadmirer
    With all the activity so far wonder if we will still get a big accumulating buy around 2 pm.
  • K
    Kalim
    Kalim
    will close with more than one millions volume... on a positive green path
  • D
    Doctor
    Doctor
    AEZS and bitcoin are the only things in my portfolio in the green today. Very good sign for both.
  • K
    Kalim
    Kalim
    Dec is knocking and smart money knows it very well. upward movement is all set. Next company's news seem quite positive most likely
  • z
    zack
    zack
    If volume sustain the million then someone knows something is happening . Otherwise it's pump to dump on trades!!! Closing price may be indicator!!
  • K
    Kalim
    Kalim
    day traders bailing out 😀...longs are looking good though
  • z
    zack
    zack
    Pre-market shows uptick . Let see how much volume in the first hour!! If volume sustains continuous millions then it may be FDA news sooner than expected!!
  • z
    zack
    zack
    Heavy buying came in the morning to 11am and diminished afterwards. Selling came in as day traders bail out!! Now the wait for 3pm to closing!!
  • z
    zack
    zack
    Let see if the volume will sustain and go pass average. Today is prove how well & real yesterday is!!!
  • K
    Kalim
    Kalim
    smart money accumulating at this point as we all can see. the stage is getting ready for upward move
  • G
    GreatDayGuraCA#2
    GreatDayGuraCA#2
    ACRX's Dsuvia PDUFA date is October 12th (FDA approval decision). ACRX's high analyst price target is $13 or 300% potential upside. Why is AEZS up 8%?????
  • z
    zack
    zack
    Closing at $2.25 means more up momentum tomorrow !!
  • z
    zack
    zack
    If volume surpass 20 mils and sustains then FDA news is very soon!!
  • R
    Raj
    Raj
    AEZS investors just go into hibernation for a month. When you're back you'll have a surprise. A good surprise of course!
  • A
    Aaron
    Aaron
    I wouldn't touch this with a ten foot stick.
  • C
    Chrissy
    Chrissy

    Unknown & deep brutally Undervalued ....
    SNOA (MC $23 M) (Cash $13 M) Shares Out: 4.3 M / NO Debt / 17 FDA approved products some of them are in early launch phase plus additional Product launches expected within 6 months / Profitable in 2018 = 1000%+ UPSIDE POTENTIAL..GLTA

    Sonoma Pharma (Nasdaq: SNOA)

    Market Cap: 22.9 Million
    Cash: $12.6 Million
    Price: $5.50

    Shares Out : 4.3 Million

    Presentation
    http://ir.sonomapharma.com/common/download/download.cfm?companyid=ocls&fileid=945547&filekey=F57B6874-6CD1-4205-A160-8E08BBB7A928&filename=SonomaPharma_Investor_presentation_13June2017.pdf

    Fact Sheet
    http://files.shareholder.com/downloads/OCLS/4977255852x0x231236/39d834a3-8462-40ee-8650-e0945b6facd5/Sonoma_Fact_Sheet.pdf

    Driving to commercial EBITDAS breakeven, without dilution

    Grow current product portfolio with all sales people

    •Alevicyn HydroGel, Dermal Spray & Spray Gel for atopic dermatitis & dermal procedures •Celacyn for scar treatment
    •Mondoxyne for severe acne –launched late 2015
    •Ceramax for skin repair in atopic dermatitis–launched in April 2016
    •SebuDerm for seborrhea dermatitis –launched in November 2016

    Launch 3 New Products –our product pipeline –one every other quarter

    •Launching Loyon–Fall 2017
    •Ceramax in foam and gel forms –Q4 2017 & Q1 2018

    Launch and Grow New and Current Products: During fiscal year 2017, we launched four new dermatology products, including SebuDerm™, Ceramax™, Lasercyn™ Gel and Lasercyn™ Dermal Spray, bringing us to a total of eight dermatology products for the treatment of atopic and seborrheic dermatitis, scar management, surgical procedures, severe acne and “state of the art” skin repair technology. We also obtained three new FDA clearances, now totaling 16 overall. Our strong intellectual property portfolio consists of 63 issued patents and 33 patent applications pending.

    We plan to launch our new FDA approved product Loyon® (a skin descaler currently marketed in Europe) in the upcoming months and have a strong product pipeline of several product line improvements, including a line extension of Ceramax™. All in all, we believe this could possibly be our best product line of new FDA approved dermatology and skincare products yet, and we believe our innovation plan will help lead us to profitability.

  • r
    redheadadmirer
    redheadadmirer
    @Zach: by December 31st does not mean on December 31st there is all the time between now and then.